Amgen Total Revenue from 2010 to 2026

AMGN Stock   28.58  0.73  2.62%   
Amgen CDR Total Revenue yearly trend continues to be very stable with very little volatility. Total Revenue is likely to drop to about 34.3 B. Total Revenue is the total amount of income generated by the sale of goods or services related to Amgen CDR's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2010-12-31
Previous Quarter
36.8 B
Current Value
34.3 B
Quarterly Volatility
3.4 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Amgen CDR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen CDR's main balance sheet or income statement drivers, such as Tax Provision of 1 B, Selling General Administrative of 7 B or Total Revenue of 34.3 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen CDR Valuation or Volatility modules.
  
This module can also supplement various Amgen CDR Technical models . Check out the analysis of Amgen CDR Correlation against competitors.
Evaluating Amgen CDR's Total Revenue across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen CDR's fundamental strength.

Latest Amgen CDR's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Amgen CDR over the last few years. Total revenue comprises all receipts Amgen CDR generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Amgen CDR's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen CDR's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

Amgen Total Revenue Regression Statistics

Arithmetic Mean27,932,541,176
Geometric Mean27,763,042,562
Coefficient Of Variation12.08
Mean Deviation2,461,651,211
Median26,323,000,000
Standard Deviation3,373,359,128
Sample Variance11379551.8T
Range10.4B
R-Value0.69
Mean Square Error6321998.1T
R-Squared0.48
Significance0
Slope462,418,137
Total Sum of Squares182072828.9T

Amgen Total Revenue History

202634.3 B
202536.8 B
202433.4 B
202328.2 B

About Amgen CDR Financial Statements

Amgen CDR investors utilize fundamental indicators, such as Total Revenue, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue36.8 B34.3 B

Pair Trading with Amgen CDR

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen CDR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen CDR will appreciate offsetting losses from the drop in the long position's value.

Moving against Amgen Stock

  0.6DR Medical FacilitiesPairCorr
  0.52AUUA Aluula Composites Earnings Call This WeekPairCorr
  0.51GMA Geomega ResourcesPairCorr
  0.49MRK MerckPairCorr
  0.47LLY Eli LillyPairCorr
The ability to find closely correlated positions to Amgen CDR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen CDR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen CDR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen CDR to buy it.
The correlation of Amgen CDR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen CDR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen CDR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Amgen Stock

Amgen CDR financial ratios help investors to determine whether Amgen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amgen with respect to the benefits of owning Amgen CDR security.